Sanofi wins vax approval; Takeda invests in Fate; Bayer wins fast track status;

 @FierceBiotech: How to play the game of naming new drugs. Story | Follow @FierceBiotech

 @JohnCFierce: Last summer, analysts were valuing EDT at $1B-$1.3B. Wonder what they think of the $960M deal. Follow @JohnCFierce

> Sanofi has won FDA approval of its Fluzone Intradermal vaccine, which uses a tiny needle for injections. Report

> Japan's Takeda has invested in Fate Therapeutics, a San Diego-based biotech which is developing stem cell technology. Story

> Orexigen says it has submitted a new plan to retest its obesity drug Contrave. The FDA had demanded a new study to investigate potential cardiovascular safety issues. Story

> Bayer has won fast track status for regorafenib, an experimental drug for gastrointestinal stromal tumors. Story

> European regulators have signed off on Biogen Idec's plan to start a pediatric trial for its new treatment of hemophilia B. Report

Pharma News

@FiercePharma: Pharma CEOs lost in the executive-pay shuffle. Story | Follow @FiercePharma

> HHS audit criticizes antipsychotic use in elderly. Story

> AZ chief: Industry stats skewed by overstated U.S. prices. Article

> Feds target Forest again with Justice subpoena. Report

> Aurobindo mulls sale of fast-growing API unit. Item

Biotech Research News

> Viruses could solve problem of hard-to-treat pancreatic cancer. Report

> Sexual orientation linked to cancer survival. News 

> Study ties chronic acetaminophen use to blood cancers. Article 

> Stem cells help create blood vessels and save life of girl. Item 

> WV's Marshall Institute means business when it comes to biotech research. Story 

> Scientists rethink serotonin, discover functions outside the brain. News 

Manufacturing News

> American Regent clears one contamination recall, starts another. Article

> Alkermes gains manufacturing strength with EDT pickup. Report

> Zacks rewards Perrigo's speedy QA turnaround. News

> Zenotech strikes over Ranbaxy/Daiichi management. Story

> NJ pharmacist murder draws Purdue reward incentive. News

> Gang poses online as carrier, steals shipments. Item

And Finally... Researchers at Caltech and Ireland's Trinity College Dublin say that a certain region of the brain drives different types of decision-making behaviors. Report

Suggested Articles

WuXi names Dong to helm new vaccines CDMO; Paragon appoints Jimenez as capital makers lead; Levy joins Spark as CMO.

The phase 1 and 2 results suggest the vaccine may be safe, tolerable and capable of triggering production of antibodies against the coronavirus.

The platform, which is in use at companies including Agios, enables researchers to simultaneously detect DNA and protein changes in single cells.